SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-005444
Filing Date
2022-02-24
Accepted
2022-02-24 19:03:36
Documents
1
Period of Report
2022-02-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4300
  Complete submission text file 0001493152-22-005444.txt   5744
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Issuer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7946 IVANHOE AVENUE, SUITE 201 LA JOLLA CA 92037
Business Address
Birkett Kevin Geoffrey (Reporting) CIK: 0001867942 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38306 | Film No.: 22673595